|120.0 mg (EU2EU)||21 capsules||€120.00|
|120.0 mg (EU2EU)||42 capsules||€150.00|
|120.0 mg (EU2EU)||63 capsules||€171.00|
|120.0 mg (EU2EU)||84 capsules||€197.00|
|120.0 mg (EU2EU)||105 capsules||€224.00|
|120.0 mg (EU2EU)||126 capsules||€250.00|
Alli is an inhibitor of gastrointestinal lipase.
One pill of Alli incorporates such an active detail as Orlistat - 100 twenty mg, and additional additives collectively with Carboxymethyl starch sodium, microcrystalline cellulose, povidone, talc, sodium lauryl sulfate.
Alli is a particular inhibitor of gastrointestinal lipases. The mechanism of its lively substance is because of the formation within the lumen of the small gut and belly a covalent bond with the lively serine center of pancreatic and gastric lipases. As a result, the enzyme that has lost activity is not succesful to break down the fat that come from food inside the form of triglycerides.
beneath the activeness of the drug, that is 24–forty eight hours after its use, the awareness of fats inside the stool mass increases. by means of decreasing the fats, Alli offers manage of body weight. For the powerful motion of the drug, it is not required its absorption into the systemic movement.
warning symptoms for the treatment of weight troubles, collectively with the availability of reducing and keeping body weight, in combination with a low-calorie food regimen;
age as tons as 18 years;
being pregnant and breastfeeding;
simultaneous use with cyclosporine;
hypersensitive reaction to any of the components of the drug.
Take the drug with caution when you have nephrolithiasis (the presence of calcium oxalate stones).
aspect consequences of Alli are:
highly rare - stepped forward activity of transaminases and alkaline phosphatase, hepatitis;
Immune tool: rash, itching, bronchospasm, angioedema, anaphylaxis;
respiratory device, chest and mediastinal organs: very regularly - infections of the higher breathing tract.